HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 30 filers reported holding HORIZON PHARMA INVT LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $5,534,000 | +95.4% | 4,175,000 | +72.2% | 0.10% | +85.7% |
| Q3 2019 | $2,832,000 | +9.6% | 2,425,000 | +4.3% | 0.06% | +16.7% |
| Q2 2019 | $2,584,000 | -64.5% | 2,325,000 | -63.6% | 0.05% | -65.2% |
| Q1 2019 | $7,284,000 | -84.6% | 6,385,000 | -86.5% | 0.14% | -68.1% |
| Q4 2018 | $47,380,000 | +13.7% | 47,408,000 | +14.8% | 0.43% | -23.0% |
| Q3 2018 | $41,677,000 | -6.2% | 41,281,000 | -10.8% | 0.56% | -9.7% |
| Q2 2018 | $44,449,000 | +28.8% | 46,262,000 | +23.4% | 0.62% | +13.5% |
| Q1 2018 | $34,517,000 | +41.5% | 37,487,000 | +43.5% | 0.55% | +43.2% |
| Q4 2017 | $24,396,000 | +263.3% | 26,127,000 | +253.2% | 0.38% | +282.0% |
| Q3 2017 | $6,715,000 | -83.2% | 7,397,000 | -82.4% | 0.10% | -83.1% |
| Q4 2016 | $40,000,000 | -15.0% | 42,060,000 | -13.0% | 0.59% | -2.9% |
| Q3 2016 | $47,069,000 | +25.0% | 48,360,000 | +18.0% | 0.61% | -9.7% |
| Q2 2016 | $37,662,000 | +72.5% | 40,989,000 | +62.0% | 0.68% | +72.7% |
| Q1 2016 | $21,835,000 | – | 25,307,000 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|